As IAPs have a diverse and complex function in several processes including apoptosis, necroptosis and the NF-κB pathway, and MM patients show a pronounced genetic heterogeneity as well as in drug response, further studies are needed to elucidate the function of IAPs in MM. This evidence concerns the gene NFKB1 and Miyoshi myopathy.